Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614808 · ClinicalTrials.gov registry record
Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 90
- Enrollment target
NCT01614808: Completed study, sponsored by Children's Oncology Group.
NCT01614808 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01614808 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This research study is looking at biomarkers in urine samples from patients with Wilms tumor. Studying samples of urine from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-06 |
What the finished NCT01614808 record still lists
NCT01614808 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01614808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01614808 about?
NCT01614808 is a clinical study titled "Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor". This research study is looking at biomarkers in urine samples from patients with Wilms tumor. Studying samples of urine from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond ...
What is the current status of trial NCT01614808?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2012-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01614808?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01614808?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia